GSA Capital Partners’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,681
Closed -$904K 2034
2022
Q3
$904K Buy
3,681
+1,714
+87% +$463K 0.12% 207
2022
Q2
$487K Buy
+1,967
New +$531K 0.07% 521
2021
Q4
Sell
-3,185
Closed -$1.04M 1937
2021
Q3
$1.04M Buy
+3,185
New +$1.08M 0.11% 300
2020
Q2
Sell
-2,062
Closed -$299K 1255
2020
Q1
$299K Sell
2,062
-4,899
-70% -$813K 0.08% 494
2019
Q4
$1.19M Buy
6,961
+5,169
+288% +$958K 0.14% 138
2019
Q3
$319K Sell
1,792
-1,134
-39% -$245K 0.04% 846
2019
Q2
$762K Sell
2,926
-9,995
-77% -$2.65M 0.09% 399
2019
Q1
$3.69M Buy
+12,921
New +$4.29M 0.37% 13
2017
Q2
Sell
-2,167
Closed -$271K 2030
2017
Q1
$271K Sell
2,167
-7,995
-79% -$927K 0.01% 1432
2016
Q4
$1.15M Sell
10,162
-599
-6% -$69.4K 0.07% 491
2016
Q3
$1.38M Sell
10,761
-7,290
-40% -$873K 0.07% 422
2016
Q2
$1.97M Buy
18,051
+10,289
+133% +$1.02M 0.11% 248
2016
Q1
$736K Buy
7,762
+2,600
+50% +$219K 0.05% 738
2015
Q4
$466K Sell
5,162
-11,251
-69% -$955K 0.02% 1203
2015
Q3
$1.52M Sell
16,413
-860
-5% -$75.8K 0.07% 391
2015
Q2
$1.14M Buy
17,273
+2,257
+15% +$150K 0.04% 780
2015
Q1
$1.07M Buy
+15,016
New +$815K 0.04% 807
2014
Q4
Sell
-9,216
Closed -$229K 1957
2014
Q3
$229K Buy
+9,216
New +$233K 0.01% 1439
2014
Q2
Sell
-21,116
Closed -$550K 2005
2014
Q1
$550K Sell
21,116
-2,914
-12% -$80.6K 0.04% 714
2013
Q4
$643K Buy
24,030
+7,014
+41% +$173K 0.05% 641
2013
Q3
$324K Buy
+17,016
New +$389K 0.03% 1086

Other funds holding ABMD

GSA Capital Partners's ABMD Position: Q4 2022 in Review

GSA Capital Partners sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 3,681 shares — an estimated $904K sold.

GSA Capital Partners first reported a position in ABMD in Q3 2013 and held it in 21 quarters. The position peaked at $3.69M in Q1 2019. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • GSA Capital Partners reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • GSA Capital Partners sold 3,681 Abiomed Inc shares in Q4 2022, an estimated $904K.
  • GSA Capital Partners first reported a position in Abiomed Inc in Q3 2013 and held it in 21 quarters.
  • GSA Capital Partners's Abiomed Inc position peaked at $3.69M in Q1 2019.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on GSA Capital Partners's 13F filing for Q4 2022, filed 13 Feb 2023.